Owens & Minor Sells P&HS Segment for $375 Million, Becomes Accendra Health
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 31 2025
0mins
Should l Buy ?
Source: Newsfilter
- Strategic Transformation Completed: Owens & Minor has successfully sold its Products & Healthcare Services segment for $375 million in cash, transforming into Accendra Health, a focused player in the home-based care market, thereby enhancing its competitive edge in this rapidly growing sector.
- Core Business Focus: This transaction allows the company to concentrate on its Apria and Byram brands, optimizing capital deployment and corporate strategy, which will improve operational efficiency and create long-term value to meet the home care needs of patients with chronic conditions.
- Equity Retention and Tax Advantages: The deal includes a 5% retained equity stake and preserves tax attributes exceeding $150 million, which will support future financial flexibility and bolster investor confidence.
- Positive Future Outlook: CEO Edward A. Pesicka stated that the new strategic direction will make Accendra Health more resilient, enabling it to better respond to market changes and seize long-term growth opportunities in the home care sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
